✅ #ENVISAGE-TAVI AF trial: edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients with #AFIb after #TAVI

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #APAF-CRT trial: ablation plus #CRT is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent #AFib patients with a narrow QRS

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅#DECAAF II trial: fibrosis #ablation shows promise in #AFib with low grade fibrotic myopathy

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫